Site Search
Search Results
2025 New Jersey Legislative Priorities
... Network (ACS CAN) will work with the New Jersey Legislature on legislative and regulatory efforts that provide affordable, adequate access to biomarker testing, ensure adequate appropriations funding for lifesaving cancer screening programs, and enact prevention policies that help people who use ... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes ...
2025 New Jersey Cancer Action Week
... state leaders to discuss our cancer legislative and budget priorities. Cancer Action Week Legislative Asks: Expand coverage and access to biomarker testing. Pass copay accumulator legislation (S3818/A5217), which would improve access to prescription drugs by ensuring copay assistance is counted ... Maintain funding for the New Jersey Cancer Education and Early Detection Screening Program (NJCEED) at $5 Million. Event Resources: New Jersey Biomarker one pager New Jersey Step Therapy Copay Accumulator New Jersey Commission on Cancer Research New Jersey Cancer Education and Early ...
Governor Murphy Sets Sights on Affordability Concerns in 2025, Advocates Applaud & Urge Lawmakers to Prioritize Patients across Cancer Continuum
... barriers that inhibit people from completing the screening process. Helping patients avoid ineffective treatment through increased access to biomarker testing: “Biomarker testing provides doctors with information about what treatment their patients will best respond to, helping patients more effectively and ...
Legislative Action Needed to Reduce the Burden of Cancer on New Jerseyans
... insurance can find themselves with medical debt. The problem for these patients is that their insurance may not cover medically appropriate testing and treatments. This forces many New Jerseyans to choose between their physical and financial health. For example, some health insurance plans may not cover the biomarker testing that a patient needs. This testing is a game-changer in the fight against cancer and an essential step in accessing precision ... looking to change that and increase access to this revolutionary testing by requiring state-regulated health plans, including Medicaid, to cover biomarker testing for patients who can benefit. “As we pursue the aforementioned opportunities to assist current patients, we must also consider ...
Mother, Daughter Survive Cancer & Send Message to Lawmakers: Reduce the Burden of Cancer in New Jersey
... mother-daughter duo will join fellow patient advocates, medical leaders and public health allies in advancing legislation to improve access to biomarker testing, eliminate financial barriers to prostate cancer screening and end the casino loophole in the New Jersey Smoke-free Air Act. 39-year-old ... individuals,” said Julie. “Where we can’t prevent disease, we should equip patients with the best tools to fight their illness, and biomarker testing makes that possible by connecting patients to personalized treatment. But lack of insurance coverage limits who can receive the ...